1-6 of 6
P. Fu
Close
Sort by
Journal Articles

DA-EPOCH-R for High Grade B-Cell Lymphoma Patients with MYC and BCL2 and/or BCL6 Rearrangements: Clinical Results of the Induction Phase of the HOVON-152 Trial

A.Vera de Jonge, Marie José Kersten, Erik van Werkhoven, Marjolein van der Poel, Koen de Heer, Clara Klerk, Yorick Sandberg, Rozemarijn S Van Rijn, Rob Fijnheer, Pim Mutsaers, Vibeke Vergote, Djamila Issa, Aart Beeker, Yavuz M. Bilgin, Lara H. Böhmer, Laurens Nieuwenhuizen, Wendy Stevens, Roel JW van Kampen, Rogier Mous, Marc Durian, Tjeerd Snijders, Joost S.P Vermaat, Otto Visser, Josée M. Zijlstra, Henk Hofwegen, Helma G.J.M. Zanders, Liping P. Fu, Daphne De Jong, Marcel Nijland, Martine E.D. Chamuleau
Journal: Blood
Blood (2023) 142 (Supplement 1): 3090.
https://doi.org/10.1182/blood-2023-181707
Published: 2023
Journal Articles

Human complete NFAT1 deficiency causes a triad of joint contractures, osteochondromas, and B-cell malignancy

Mehul Sharma, Maggie P. Fu, Henry Y. Lu, Ashish A. Sharma, Bhavi P. Modi, Christina Michalski, Susan Lin, Joshua Dalmann, Areesha Salman, Kate L. Del Bel, Meriam Waqas, Jefferson Terry, Audi Setiadi, Pascal M. Lavoie, Wyeth W. Wasserman, Jill Mwenifumbo, Michael S. Kobor, Anna F. Lee, Florian Kuchenbauer, Anna Lehman, Sylvia Cheng, Anthony Cooper, Millan S. Patel, Stuart E. Turvey
Journal: Blood
Blood (2022) 140 (17): 1858–1874.
https://doi.org/10.1182/blood.2022015674
Published: 2022
Includes: Supplemental data
Journal Articles

Analyses of Prognostic Factors for Survival in East African Patients with AIDS-Related Non-Hodgkin’s Lymphoma (AR-NHL) Treated with Dose Modified Oral Chemotherapy.

Vivek Subbiah, MD, O.W. Mwanda, MD, Jackson Orem, MD, P. Fu, C. Banura, J. Kakembo, A. Ness, J. Johnson, J. Bako, E. Katongole-Mbidde, Scot Remick, MD
Journal: Blood
Blood (2006) 108 (11): 3862.
https://doi.org/10.1182/blood.V108.11.3862.3862
Published: 2006
Journal Articles

Umbilical Cord Blood (UCB) Graft T-Cells Correlate with Myeloid Recovery in Adults with Hematologic Malignancies Treated with Reduced Intensity Conditioning (RIC) and Single Unit Infusion.

Y. Hegerfeldt, L.R. Fanning, P. Fu, H.M. Lazarus, B. Cooper, W. Tse, H. Meyerson, S.L. Gerson, J. Jaroscak, R. Fox, R. Creger, J. Maciejewski, M. Tary-Lehmann, M. Ratajczak, C. Stevens, P. Rubinstein, M.A. Hoffman, Mary J. Laughlin
Journal: Blood
Blood (2006) 108 (11): 3132.
https://doi.org/10.1182/blood.V108.11.3132.3132
Published: 2006
Journal Articles

Dose-Modified Oral Chemotherapy for AIDS-Related Non-Hodgkin’s Lymphoma (AR-NHL) in East Africa.

Jackson Orem, MD, O.W. Mwanda, MD, P. Fu, C. Banura, J. Kakembo, A. Ness, J. Johnson, V. Subbiah, MD, J. Bako, J. Black, E. Katongole-Mbidde, S.C. Remick, MD
Journal: Blood
Blood (2006) 108 (11): 488.
https://doi.org/10.1182/blood.V108.11.488.488
Published: 2006
Journal Articles

Umbilical Cord Blood CD133 + Stem Cells Exhibit Vasculogenic Capacity In Vitro and Augment Neovasculogenesis In Vivo in a Murine Model of Vascular Ischemia.

M.R. Finney, MS, L.R. Fanning, BS, P.J. Vincent, MD, D.G. Winter, BS, M.A. Hoffman, K.J. Antepara, N.J. Greco, PhD, M. Kozik, BS, M.E. Joseph, BS, P. Fu, PhD, Mary J. Laughlin, MD
Journal: Blood
Blood (2006) 108 (11): 1790.
https://doi.org/10.1182/blood.V108.11.1790.1790
Published: 2006